These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5652207)

  • 1. [Theoretical and experimental bases for the polychemotherapy of cancer].
    Delobel J; Mawas C; Israel L
    Poumon Coeur; 1968; 24(1):5-8. PubMed ID: 5652207
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic synergism.
    Mantal N
    Cancer Chemother Rep 2; 1974 Mar; 4(1):147-9. PubMed ID: 4826493
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current aspects of drug therapy of cancer].
    Vicente J
    Rev Clin Esp; 1970 Dec; 119(6):501-16. PubMed ID: 4928318
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 6-azauridine on plasma cell tumors of mice: correlation of antitumor effect with inhibition of orotic acid metabolism.
    Conn HO; Creasey WA; Calabresi P
    Cancer Res; 1967 Apr; 27(4):618-25. PubMed ID: 6071670
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug activity and therapeutic synergism in cancer treatment.
    Carter WH; Wampler GL; Stablein DM; Campbell ED
    Cancer Res; 1982 Aug; 42(8):2963-71. PubMed ID: 6807534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticancer polychemotherapy of human tumors. Theoretical and practical problems].
    Israel L
    Poumon Coeur; 1968; 24(1):15-9. PubMed ID: 5652201
    [No Abstract]   [Full Text] [Related]  

  • 8. An empirical cellular approach to the improvement of cancer chemotherapy.
    Bruce WR; Lin H
    Cancer Res; 1969 Dec; 29(12):2308-13. PubMed ID: 5369679
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on antineoplastic properties of the hydrochloride salt of Kirghiz Aconitum bases and of its alkaloids under experimental conditons].
    Petrov AA
    Sov Zdravookhr Kirg; 1965; 4():28-33. PubMed ID: 5880448
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological properties of mono- and bisquanylhydrazones].
    Wollert U
    Arzneimittelforschung; 1969 Apr; 19(4):680-3. PubMed ID: 4894141
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental methodology for the selection of potential anticancer agents].
    Pérez Mínguez F; Llombart Bosch A
    Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of P-glycoprotein with respect to the application of resistance modifiers.
    Scheulen ME
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):41-5. PubMed ID: 9476147
    [No Abstract]   [Full Text] [Related]  

  • 13. [Polychemotherapy in the course of bronchopulmonary polymitoses].
    Baudouin R; Gaillot MJ; Jacques G
    Therapie; 1968; 23(4):961-70. PubMed ID: 5744600
    [No Abstract]   [Full Text] [Related]  

  • 14. A quick reference chart on cross resistance between anticancer patients.
    Skipper HE; Hutchison DJ; Schabel FM; Schmidt LH; Goldin A; Brockman RW; Venditti JM; Wodinsky I
    Cancer Chemother Rep; 1972 Aug; 56(4):493-8. PubMed ID: 5081592
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polychemotherapy of bronchopulmonary cancer].
    Morere P; Chauvet MC; Vaudour P; Maisse P; Stain JP; Lenail C
    Poumon Coeur; 1968; 24(1):111-6. PubMed ID: 5661796
    [No Abstract]   [Full Text] [Related]  

  • 16. Practices and pitfalls of mouse cancer models in drug discovery.
    Kung AL
    Adv Cancer Res; 2007; 96():191-212. PubMed ID: 17161681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 18. The mighty mouse: genetically engineered mouse models in cancer drug development.
    Sharpless NE; Depinho RA
    Nat Rev Drug Discov; 2006 Sep; 5(9):741-54. PubMed ID: 16915232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin and cancer.
    Zacharski LR; Ornstein DL
    Thromb Haemost; 1998 Jul; 80(1):10-23. PubMed ID: 9684778
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L
    Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.